B.C. begins offering in-province immunotherapy treatment for lymphoma, leukemia

B.C. Health Minister Adrian Dix speaks during a health-care funding announcement, in Vancouver on February 12, 2024. THE CANADIAN PRESS/Darryl Dyck

VANCOUVER - British Columbia is beginning to offer an immunotherapy cancer treatment in the province for some patients who haven't had success with standard chemotherapy or radiation.

Chimeric antigen receptor T-cell Therapy, commonly referred to as CAR-T, treats lymphoma and leukemia by collecting a patient's white blood cells and genetically engineering them to recognize and kill cancer cells.

The ºÃÉ«tv Press. All rights reserved.

More Health Stories

Sign Up to Newsletters

Get the latest from ºÃÉ«tvNews in your inbox. Select the emails you're interested in below.